Expert Review of Clinical Pharmacology

Papers
(The TQCC of Expert Review of Clinical Pharmacology is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Personalizing tamoxifen therapy in adjuvant therapy: a brief summary of the ongoing discussion57
A review of current and emerging therapies in breast cancer: implications for older adults56
Renin angiotensin aldosterone inhibitors in the treatment of proteinuria in children with congenital anomalies of the kidney and urinary tract: more evidence needed41
Therapeutic drug monitoring of antiretroviral therapy: current progresses and future directions40
Prostate cancer and novel pharmacological treatment options–what’s new for 2022?40
Sparsentan: a dual endothelin and angiotensin II receptor antagonist approved for IgA nephropathy39
Reducing the risk of death – a possible outcome in COPD patients39
Strategies for lowering lipoprotein(a): a spotlight on novel pharmacological treatments36
A simulation study to assess the influence of population pharmacokinetic model selection on Bayesian forecasting of vancomycin exposure in preterm neonates35
Practical considerations and emerging approaches for the management of vasomotor and sexual symptoms in breast cancer patients on endocrine therapies32
Sodium-glucose cotransporter 2 inhibitors in frail, older people with type 2 diabetes and heart failure: do we have enough evidence to confidently support the use?31
JAK inhibitors in dermatology: the road travelled and path ahead, a narrative review30
Complement C5 inhibitor crovalimab for the treatment of paroxysmal nocturnal hemoglobinuria30
Pharmacological and clinical profile of ravulizumab 100 mg/mL formulation for paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome30
Effects of the augmentation with quetiapine or olanzapine on the metabolism of duloxetine: a retrospective analysis27
Management of polypharmacy through deprescribing in older patients: a review of the role of AI tools25
What is the potential for abuse of lisdexamfetamine in adults? A preclinical and clinical literature review and expert opinion24
Clinical pharmacology of antiplatelet drugs24
Risk of new onset diabetes mellitus with pitavastatin as compared to atorvastatin and rosuvastatin: a systematic review and meta-analysis23
Amylin analogs for the treatment of obesity without diabetes: present and future23
Clinical efficacy and safety of topical difamilast in the treatment of patients with atopic dermatitis: a systematic review and meta-analysis of randomized controlled trials22
Brimonidine tartrate ophthalmic solution 0.025% for redness relief: an overview of safety and efficacy22
Cannabidiol drug interaction considerations for prescribers and pharmacists21
Role of tenecteplase in ischemic stroke after 4.5 hours: an evaluation of the TRACE-III trial20
Treatment management for rosacea: current pharmacological and non-pharmacological options20
Profiling the pattern of medication use during pregnancy: an international scoping review of observational studies19
Nicotine e-cigarettes for smoking cessation: a clinical pharmacology perspective18
Medical management of pediatric chronic rhinosinusitis18
Reply to: The risk for genito-urinary infections with sodium-glucose cotransporter-2 inhibitors: duration rather than dose matter?18
Broadening access to tenofovir alafenamide for the treatment and prevention of HIV-1 infection18
Complications related to oral corticosteroid use in asthma patients: a retrospective cohort study17
The thiazide-like diuretic chlorthalidone as an alternative evidence-based therapy for resistant hypertension in patients with stage 4 chronic kidney disease17
Nirmatrelvir/Ritonavir and molnupiravir: an update on COVID-19 antivirals in the Omicron era17
CYP2C19 genotype-guided dosing of proton pump inhibitors: progress in clinical trials and real-world use16
Reconsidering molecular pathways in giant benign prostatic hyperplasia: a potential strategy for an unmet challenge16
Drug-drug interactions associated with FLT3 inhibitors for acute myeloblastic leukemia: current landscape16
Intestinal microbiome and epilepsy: a new therapeutic approach?16
OPTIMA-ID: development and validation of a medicine optimization tool for older adults with intellectual disability16
Pharmacological strategies for the management of the antisocial personality disorder16
Pediatric attention deficit hyperactivity disorder (ADHD): 2022 updates on pharmacological management15
Hydroxyurea in the sickle cell disease modern era15
Clinical pharmacology of SGLT-2 inhibitors in heart failure15
Clozapine for older adults with severe mental illness: a systematic review and expert recommendations for clinical practice15
Population pharmacokinetic modeling and exposure-response analysis of anrikefon: insights and implications in clinical analgesia15
Recent advances and unmet needs in the treatment of drug-resistant tuberculosis15
A profile of azetukalner for the treatment of epilepsy: from pharmacology to potential for therapy15
Could GLP-1RAs improve outcomes for patients with chronic migraine?15
Association between sodium-glucose cotransporter 2 inhibitors and eye disorders: a systematic review and meta-analysis15
Innovation in pediatric atopic dermatitis care: examining emerging topical treatment options14
Population pharmacokinetic modeling of piperacillin in critically ill adult patients: consideration of sex-based differences during model development14
Current and emerging pharmacotherapies for treating vascular malformations14
FLOT vs CROSS in localized esophageal adenocarcinoma: what is the current best strategy?14
Osteoarthritis and cardiometabolic diseases: shared mechanisms, modifiable risk factors, and integrated management strategies14
Revisiting the association between sodium-glucose cotransporter-2 inhibitors and the risk of neoplasm in patients with type 2 diabetes: new insights from an updated systematic review and meta-analysis14
A narrative review of non-racemic amisulpride (SEP-4199) for treatment of depressive symptoms in bipolar disorder and LB-102 for treatment of schizophrenia14
The nocebo phenomenon in the COVID-19 pandemic: a nocebodemic effect13
Risk factors for a broken heart: understanding drug-induced causes for Takotsubo syndrome and pharmacological treatment options13
Pharmacotherapy for previously treated gastric cancer patients: current options and future developments13
Efficacy and safety of tislelizumab for malignant solid tumor: a systematic review and meta-analysis of phase III randomized trials13
Phosphatidylinositol 3 kinase inhibitor-related pneumonitis: a systematic review and meta-analysis13
An observational study of safety and clinical outcome measures across patient groups in the United Kingdom Medical Cannabis Registry13
Early response is a strong predictor of the long-term response in psoriasis patients receiving risankizumab or guselkumab in the real-world: a retrospective analysis13
Methenamine Hippurate in UTI management: a reemerging pharmacological strategy13
Progress in the pharmacological management of vasovagal syncope13
A systematic review and meta-analysis of users versus non-users: unveiling the influence of proton pump inhibitors on capecitabine efficacy in colorectal cancer13
Pharmacogenomics – a minor rather than major force in clinical medicine12
Biosimilars for chronic plaque psoriasis: a 2026 update12
Methotrexate polyglutamates12
Real-world clinical effectiveness of once-weekly semaglutide in patients with type 2 diabetes: a systematic literature review12
Physiologically-based pharmacokinetic modeling to predict the exposure and provide dosage regimens of adalimumab in patients with juvenile idiopathic arthritis12
Shaping future deprescribing priorities: outcomes of a World Café stakeholder workshop12
Optimization of secukinumab dose regimens in patients with moderate-to-severe plaque psoriasis via exposure-response modeling11
Pharmacokinetic interaction of quetiapine and lamotrigine – victim and perpetrator?11
Emerging pharmacological options in the treatment of idiopathic pulmonary fibrosis (IPF)11
Designer benzodiazepines: an update11
PREG-ADR: development and validation of a predictive tool for adverse drug reactions in hospitalized pregnant women11
Comparison of dopamine D2 receptor occupancy profiles between risperidone ISM versus oral risperidone and monthly paliperidone palmitate based on population pharmacokinetic modelling and simulations10
Encouraging appropriate use of proton pump inhibitors: existing initiatives and proposals for the future10
Psychedelic drugs for the treatment of substance use disorders10
The pharmacotherapeutic options in patients with catecholamine-resistant vasodilatory shock10
Genito-urinary infectious adverse events related to sodium glucose cotransporter-2 inhibitors: a network meta-analysis and meta-regression10
Pharmacology considerations for managing pregnancy in women with systemic lupus erythematosus10
TYK2 as a novel therapeutic target in psoriasis10
Interstitial lung disease associated with anti-HER2 anti-body drug conjugates: results from clinical trials and the WHO's pharmacovigilance database10
Is therapeutic drug monitoring a dancing partner for TNF-α inhibitors in real-world practice? Answers from an updated systematic review and meta-analysis10
Hormonal contraception, past, present, and future part 1: the early path – facts, stories, and controversies10
Efficacy and safety of dupilumab in chronic rhinosinusitis with nasal polyps: a systematic review and meta-analysis10
Advances in pharmacokinetic-pharmacodynamic modelling for pediatric drug development: extrapolations and exposure-response analyses10
Biomarker discovery in acetaminophen hepatotoxicity: leveraging single-cell transcriptomics and mechanistic insight10
Signal mining study of severe cutaneous adverse events of valaciclovir or acyclovir based on the FAERS database10
Clinical pharmacology of siRNA therapeutics: current status and future prospects10
Golimumab retention in patients with psoriatic arthritis and axial spondyloarthritis: evidence from up to a decade of follow-up10
The future of pharmacology education: The Veterinary Educators in Pharmacology Special Interest Group (VEPSIG)10
Revolutionizing diabetes care: unveiling tirzepatide’s potential in glycemic control and beyond10
The orexin system and alcohol use disorder: bridging the gap between preclinical and clinical research10
Pharmacological treatment for transforming growth factor beta induced corneal dystrophies: what is the way forward?9
Clozapine for treatment refractory catatonia in individuals with autism spectrum disorder: a retrospective chart review study9
Adverse clinical outcomes associated with drug-related hospitalizations in people with dementia9
Statin-related neurocognitive disorder: a real-world pharmacovigilance study based on the FDA adverse event reporting system9
Clinical outcomes of oral anticoagulant discontinuation in atrial fibrillation: a systematic review and meta-analysis9
Availability and evaluation of medication management resources for carers of people with dementia: a scoping review with an environmental scan9
Practical challenges and considerations in adopting biosimilars in oncology clinical practice within a large healthcare system9
The systems medicine view of semaglutide: from clinical trials to molecular mechanisms9
Opioid use disorder in pediatric populations: considerations for perioperative pain management and precision opioid analgesia9
Predictors of warfarin therapeutic dose across thromboembolic indications: an exploratory early clinical evaluation study using machine learning-integrated explainable artificial intelligence and Baye9
Current understanding of the etiology of cyclic vomiting syndrome and therapeutic strategies in its management9
Intravitreal immunotherapy in non-infectious uveitis: an update9
Effects of single-nucleotide polymorphism on the pharmacokinetics and pharmacodynamics of metformin8
Detrimental impact of gastric acid suppressants on vascular endothelial growth factor receptor tyrosine kinase inhibitors efficacy: evidence from a systematic review and meta-analysis8
Next-generation sequencing in pharmacogenomics – fit for clinical decision support?8
Novel and emerging treatment strategies for lupus nephritis8
Considerations when prescribing opioid agonist therapies for people living with HIV8
Optimizing outcomes and managing adverse events in locally advanced or metastatic urothelial cancer: a clinical pharmacology perspective8
Treatment and prevention of influenza in geriatric patients8
Perspectives on deprescribing in older people with type 2 diabetes and/or cardiovascular conditions: challenges from healthcare provider, patient and caregiver perspective, and interventions to suppor8
Genotype-guided pharmacotherapy: the challenges of integrating pharmacogenomic testing into routine healthcare with a focus on experiences at a single site8
Efficacy and safety of statins for nonalcoholic/metabolic dysfunction-associated fatty liver diseases: a systematic review and meta-analysis8
Vaping Δ 9 -tetrahydrocannabinol (Δ 9 -THC) in liquid forms: pharmacokinetics, pharmacodynamics, a8
1.888130903244